Tuesday, 13 August 2024
A new study, led by experts at the 糖心原创, has shown that different plant species tackle the same evolutionary hurdle in different ways, and the findings may give insight into aggressive forms of cancer.
Whole genome duplication (WGD) happens in all kingdoms of life. It is most common in plants, but also occurs in some of the most aggressive cancers. After WGD, the cell has extra genomes and is called polyploid.
Most of our major crops are also polyploid, including, wheat, apples, bananas, oats, strawberries, sugar and brassicas like broccoli and cauliflower. Polyploidy also occurs in some of the most aggressive gliomas (a brain cancer) and is associated with cancer progression. In general, polyploidy has been associated with robustness (as in crops) and adaptation to the environment (as in cancers that metastasise).
Because polyploids have more genomes to manage, the doubling of these genomes can be a weakness, so it is important to understand what factors stabilise young polyploids and how genome doubled populations evolve.
In this new study, published in Cell Reports, experts from the University’s School of Life Sciences look at how three successfully polyploid plant species evolved to manage the extra DNA and whether they each did this differently or all the same way.
Professor Levi Yant, who led the study said: “Understanding the range of issues that face polyploids may help us to understand why some succeed while others don’t. We see that successful polyploids overcome specific issues with DNA management and we focus on exactly what their ‘natural solutions’ are.
“In our study, we looked at three instances where species have adapted to ‘polyploid life’ and not only survived, but even thrived. Then we looked at whether they used the same molecular solutions to survive. Surprisingly, they did not.”
The researchers found that the clearest signal of rapid adaptation to the polyploid state came from the CENP-E molecule, which is an exact molecule that other groups recently found to be an Achillies heel for polypoid cancers, and is a promising therapeutic target to kill the cancers. The next clearest signal came from ‘meiosis genes’, which Professor Yant notes are turned on in many cancers, whereas they are turned off in nearly all normal cells.
Professor Levi Yant
“We discovered signals of rapid adaptation to the WGD state in the same molecular networks, and in the case of CENP-E, the exact molecule that is specifically important to polyploid cancers,” continues Professor Yant.
“This WGD gives cancer a short-term advantage over most therapies, but targeting that exact molecule, CENP-E, specifically kills the polyploid cancer. This is a striking example of evolutionary repetition (or convergence) from completely different directions, but to the same adaptive hurdle. We can now take this model that adapts well to polyploidy and that can inform our thinking about certain types of cancer.”
The findings of the study could impact in better understanding how certain polyploid cancers, such as gliomas (brain cancers) are able use polyploidy to progress, and what molecules can be targeted as part of any therapy to ‘kill’ the cancer cells.
More broadly, the study is important evidence that shows that mining evolutionary biology for these natural solutions can inform future therapies. Finally, the study also illustrates different ways in the future that we can better engineer our many polyploid crops to be more resilient to certain cataclysmic events – such as climate change.
The full study, which was funded by the European Research Council, BBSRC, and the Leverhulme Trust, can be found .
Story credits
More information is available from Professor Levi Yant from the School of Life Sciences at levi.yant@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.